A total of five projects supervised by Charité BIH Innovation — the joint technology transfer of Charité and BIH — have successfully qualified for the GO-Bio initial program of the Federal Ministry of Research, Technology, and Space (BMFTR). While NEUROLITH will begin the two-year feasibility phase…
The Berlin Institute of Health at Charité (BIH) successfully concluded its Digital Health Accelerator Demo Day in October 2025. The virtual event brought together clinicians, researchers, investors, and innovators in digital health to present solutions developed by those working closest to patients.…
Following the successful submission of Expressions of Interest, the next steps are underway: together with researchers at Charité and BIH, innovative projects will now be developed.
As part of its strategic internationalisation efforts, Charité – Universitätsmedizin Berlin, the Berlin Institute of Health (BIH) and Enterprise Singapore (ESG) have jointly launched a Co-Innovation Programme. With the signing of a Memorandum of Understanding (MoU) in November 2023, the foundation…
Myasthenia gravis is a rare neurological autoimmune disease characterized by fluctuating muscle weakness that worsens with activity. About 17,000 people in Germany suffer from the disease. Many struggle to access appropriate care, especially if they need complex immunotherapies. The start-up…
Do you have an innovative idea or questions concerning IP and patents? The Idea Office is a service offered by Charité BIH Innovation, the joint technology transfer of Charité and the Berlin Institute of Health (BIH). It has been organized by Bettina Otto and Thomas Marek Wallach since 2022 and was…
Applications for the SPARK-BIH funding programme 2025 are open from now until 7 July 2025. Scientists and clinicians from BIH and Charité at all career levels are invited to apply.
The TransferAllianz e.V. has published a position paper that is intended to provide the new federal government with impulses for optimal transfer promotion in Germany. Three specific measures are intended to support knowledge and technology transfer in Germany and strengthen Germany as a location…
Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) now have fixed standard terms for spin-offs. These define binding key points for spin-off projects, particularly with regard to participation and licensing of intellectual property. Clear, consistent framework conditions…
